$Hims & Hers Health Inc.(HIMS)$ Gets hit very hard on fear and bounces back. Yes the stock has been weak but in the 20s this FUD that has been spewed for months is not only bs… it’s priced in bs. Throw opex into the mix today there’s even more motivation to keep it down. Very much looking forward to next ER just a little over 2 weeks away. Since irrational short squeeze over 70… Everything negative but the kitchen sink has been thrown at this… market has been terrible on top of it. Let’s bring a little sanity back to this very insane period of trading volatility. 50 was my PT by June so when it hit that 4 months early trimming above was just gravy. At this point it is a buy not a sell imho. I admittedly added some to
1. $Alphabet(GOOG)$$Alphabet(GOOGL)$ Short-term structure remains bearish, but there’s still clear buying pressure building ahead of earnings.Price action looks rough right now — but I wouldn’t count this one out just yet.Image2. $NVIDIA(NVDA)$ I was bearish the past few days, but even with this sell-off, the BX Trender is still holding green.Wouldn’t count this one out just yet.Image3. $Wal-Mart(WMT)$ Textbook long setup last week when the BX flipped 🟢If I was already in, I would let it ride for a bit.If not, I wouldn't chaseImage4. $Hims & Hers Health Inc.(HIMS)$ Still li
CREW, AMD, NVDA, HIMS, QQQ& SPY Bears Great Pressure Now?
Hello everyone! Today i want to share some technical analysis with you!1. $Advanced Micro Devices(AMD)$ doing what it does best—dumping hard on $NVDA H20 news.AMD 🔻 -6.40%Image2. $NVIDIA(NVDA)$ 🚨 NVIDIA tumbles after hours:U.S. limits chip exports to China→ Nvidia hit with new license requirements→ Up to $5.5B in charges expected next quarterNVDA 📉 -5.60%Image3. $SPDR S&P 500 ETF Trust(SPY)$ Inside bar with an unfilled gap just overhead...Spicy setup. 🌶️Image4.Inverse $Invesco QQQ(QQQ)$ Daily Chart 🔄$467 area is the spot to hold for a continuation of trend.Image5. $Hims & Hers
$Hims & Hers Health Inc.(HIMS)$ The most bullish news for $HIMS since it operates entirely in the US and its business model was built on making healthcare affordable and accessible. Big Pharma have to burn more cash in order to sell their products at lower prices. HIMS was founded to fix this sick system.
1. $Trade Desk Inc.(TTD)$ TTD has been falling off a cliff—everyone’s trying to catch the bottom and failing.It’s down nearly 50% in just a few weeks. I think it’s finally time to buy 👇2. $Advanced Micro Devices(AMD)$ AMD bounced nearly 20% from the Smart Money Zone…and I’m still down over $100K on my position.3. $Hims & Hers Health Inc.(HIMS)$ HIMS is pulling back into the Smart Money Zone 🚀The last three times this happened, it ran over 100%.I don’t expect that again, but I’m planning to trade it and a strong bounce is still on the table.4. $Rivian Automotive, Inc.(RIVN)$ RIVN is bouncing off major Smart Money Zone s
$SoFi Technologies Inc.(SOFI)$$Hims & Hers Health Inc.(HIMS)$ SOFI and HIMS are both reporting massive growth in their website traffic.HIMS can move up really quickly in this environment. GLP1’s are just the beginning.It is an incredible feeling to own a company and watch it deliver month over month and quarter over quarter. This leadership always finds a way to get it done.
Here's 10 Undervalued Tariff-proof Stocks on My Watchlist
Effective tariff rate is still above 20% despite the 90-day pause.This will increase inflation and reduce growth.Here's 10 undervalued tariff-proof stocks on my watchlist: 🧵1. $ASML Holding NV(ASML)$ 5-Year Revenue CAGR: 14%Return on Investment: 25%Forward P/E: 24ASML holds a monopoly on EUV lithography, essential for manufacturing advanced chips.Every new AI model and vertical agent boosts chip complexity, driving demand for ASML’s machines higher.With semiconductor equipment exempt from tariffs, ASML remains the ultimate pick-and-shovel play in AI compute growth.Image2. $Taiwan Semiconductor Manufacturing(TSM)$ 5-Year Revenue CAGR: 16%Return on Investment: 26%Forward P/E: 15TSMC has expanded its overall
Trump’s Tariffs Spark Safe-Haven Surge—But Is the Market Bottom In?
The U.S. tariff wave is shaking things up, pushing the Japanese yen to multi-month highs. Meanwhile, Warren Buffett’s Berkshire Hathaway just issued ¥90 billion in yen bonds on Nov. 11, hinting at a bold bet on Japan’s top five trading companies. Could this signal the market’s bottom and the start of an uptrend? Analysts love the setup: yen-denominated bonds sidestep currency risks, and with trading firms yielding ~3% against Buffett’s ~1.5% borrowing cost, there’s a juicy ~1.5% spread to pocket. Market Pulse: Stocks may be ready to rally! Buffett’s Fortune Grows Amid Billionaire Bust! Trump’s tariffs are hitting billionaire wallets hard, but Warren Buffett’s thriving—his wealth soared $11.5 billion in 2025, or ~NT$379.1 billion monthly, making him the only top-10 billionaire gaining groun
$Hims & Hers Health Inc.(HIMS)$$Palantir Technologies Inc.(PLTR)$$NVIDIA(NVDA)$I am curious to see what the tariffs on pharmaceuticals looks like, HIMS was able to meet the supply of one designer drug. I would not be surprised if they could meet the demand for another one. They purchased a peptide manufacturing facility in late February. Either it was bought fully operational or needs some rehab, who knows, but domestically produced peptides warrants another look. This chart is mirroring Palantir and Nvidia quite well so there might be some MM, but I will be holding for a long while.
$Hims & Hers Health Inc.(HIMS)$ Hims is misperceived as a DTC pharmacy or telehealth app. In reality, it’s building a vertically integrated healthcare platform — combining software, clinical care, diagnostics, compounding, and fulfillment. This isn’t just about better margins — it’s about controlling the entire patient journey and creating a scalable, defensible infrastructure. (Moat) Once the market recognizes Hims as a core layer of consumer healthcare infrastructure, not just a front-end, the valuation shifts. True platform companies with similar vertical integration and recurring models often trade at 10–20x revenue. That re-rating isn’t hype — it’s a function of business model strength and structural positioning
I closed 2100.0 share(s) $Hims & Hers Health Inc.(HIMS)$ ,I closed $Hims & Hers Health Inc.(HIMS)$ ,Take a look at the latest order I posted！ Taking the small loss here for HIMS. Has been slightly disappointed with its price action. Will reconsider if it goes lower. Saving bullets for any further drops now
$Hims & Hers Health Inc.(HIMS)$ HIMS is in hyper - exponential growth mode. Buy common shares lock them up and watch your wealth grow exponentially over the next 1-2-3-4-5 years + hims platform is self reinforcing, the system isn’t just growing, its accelerating.
Oaktree Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the industrial and consumer sectors. The company was founded in 2019 and is based in Los Angeles, California.
04-16
Proposed Sale Of Securities
Form 144 | Hims & Hers Health's Officer Andrew Dudum proposes to sell 83,994 Shares, with a total value of approximately $2.36 Million.